Possibly UT Southwestern is not allowed to post such an estimation about ZoptEC, so they better removed the statement away from their site. But it seems to me Zoptarelin-Doxorubicin could have worked fine for Southwestern patients while treating their patients during the study.
Alot of us understand that the drug is an awesome thing~the controversy lies with dilution. Thats where everyone else does not want to tippy-toe! Any thoughts??
Does that not show that we are dealing with nasty and manipulative crooks...who else calls the hospital/Biotech comapny and requires that the last sentence must be removed. This has been pure manipulation so far and someone is feeling the heat as price was about to go higher than they expected/could allow.